×

Uh-oh, it looks like your Internet Explorer is out of date.

For a better shopping experience, please upgrade now.

Hereditary Retinopathies: Progress in Development of Genetic and Molecular Therapies
     

Hereditary Retinopathies: Progress in Development of Genetic and Molecular Therapies

by Peter Humphries, Marian Humphries, Lawrence C. S. Tam, Jane G. Farrar, Paul F. Kenna
 

The hereditary retinopathy, retinitis pigmentosa (RP), which affects 1 in 3,500 people worldwide, is the most common cause of registered visual handicap among those of the working age in developed countries. RP is a highly variable disorder where patients may develop symptomatic visual loss in early childhood, while others may remain asymptomatic until

Overview

The hereditary retinopathy, retinitis pigmentosa (RP), which affects 1 in 3,500 people worldwide, is the most common cause of registered visual handicap among those of the working age in developed countries. RP is a highly variable disorder where patients may develop symptomatic visual loss in early childhood, while others may remain asymptomatic until mid-adulthood. Most cases of RP segregate in autosomal dominant, recessive or X-linked recessive modes, with approximately 41 genes being implicated in disease pathology to date (RetNet). The extensive genetic heterogeneity associated with autosomal dominant RP (adRP) is an undisputed hindrance to the development of genetically based therapeutics.

Product Details

ISBN-13:
9781461444985
Publisher:
Springer New York
Publication date:
08/04/2012
Series:
SpringerBriefs in Genetics Series , #1
Edition description:
2012
Pages:
46
Product dimensions:
6.10(w) x 9.25(h) x 0.01(d)

Customer Reviews

Average Review:

Post to your social network

     

Most Helpful Customer Reviews

See all customer reviews